The first CBA-China Annual Conference in 2024, organized by the Chinese Biomedical and Pharmaceutical Association of the United States, was held recently. Over 20,000 professionals gathered at this event to discuss new trends, opportunities, and challenges in the field of medical health.
Professor Peng Niancai, founder of Tianlong and doctoral advisor at Xi'an Jiaotong University, was a special guest at the conference, and delivered an academic report titled "New Gene Detection Technologies Supporting Personalized Medicine and Precision Medicine."
Professor Peng discussed the significance of gene detection technology in personalized medicine and precision medicine, and introduced Tianlong's advancements and achievements in gene detection and molecular diagnostics, including diverse solutions for various fields, which has brought valuable inspiration and insights to the attendees.
